Diabetes-Induced Impairments of the Exocytosis Process and the Effect of Gabapentin: The Link with Cholesterol Level in Neuronal Plasma Membranes View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2015-01-23

AUTHORS

Irene Trikash, Vitaliy Gumenyuk, Tamara Kuchmerovska

ABSTRACT

Diabetic neuropathy represents one of the most prevalent complications of diabetes mellitus. The aim of this study was to investigate the effect of diabetes-induced disturbances in neurons on the Ca2+-triggered membrane fusion process in cell-free system in relation to plasmalemma cholesterol level. The gabapentin therapy on the exocytosis process was also studied. The diabetes in rats was induced by streptozotocin (60 mg/kg of body weight, i.p.). After 4 weeks of diabetes induction the one group of diabetic rats was treated with gabapentin (50 mg/kg, i.p.) during 1 month. Fusion experiments were performed in the cell-free model system using fluorescent dye octadecylrhodamine B. The [2-14C]serotonin preloaded synaptosomes were used for assay of stimulated neurotransmitter release. The synaptosomal plasma membrane cholesterol level in diabetic rats was on 12 % higher than in control and was decreased on 5 % after gabapentin therapy. The rate of synaptic vesicles fusion with plasma membranes in the presence of Ca2+ and synaptosomal cytosolic proteins was decreased to 14.5 % in diabetic rats as compared to control (23 %) and after gabapentin administration to diabetic rats was raised to 18 %. At diabetes the stimulated synaptosomal serotonin release was increased in 1.7–2 folds and was partially normalized by gabapentin therapy. Together, these findings suggest that elevated cholesterol content in neuronal plasma membranes at diabetes impairs the membrane fusion process in neurons that can induce the development of neuropathy. Diabetes-evoked impairments of the exocytotic process can be attenuated by gabapentin therapy. More... »

PAGES

723-732

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11064-015-1520-6

DOI

http://dx.doi.org/10.1007/s11064-015-1520-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1022299107

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25614181


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Membrane", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholesterol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclohexanecarboxylic Acids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetic Neuropathies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Exocytosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gabapentin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neurons", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Wistar", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Serotonin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "gamma-Aminobutyric Acid", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Neurochemistry Department, Palladin Institute of Biochemistry of NAS, Kiev, Ukraine", 
          "id": "http://www.grid.ac/institutes/grid.419966.5", 
          "name": [
            "Neurochemistry Department, Palladin Institute of Biochemistry of NAS, Kiev, Ukraine"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Trikash", 
        "givenName": "Irene", 
        "id": "sg:person.060040255.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.060040255.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Neurochemistry Department, Palladin Institute of Biochemistry of NAS, Kiev, Ukraine", 
          "id": "http://www.grid.ac/institutes/grid.419966.5", 
          "name": [
            "Neurochemistry Department, Palladin Institute of Biochemistry of NAS, Kiev, Ukraine"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gumenyuk", 
        "givenName": "Vitaliy", 
        "id": "sg:person.01137345775.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137345775.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Vitamines and Coenzymes Biochemistry Department, Palladin Institute of Biochemistry of NAS, Kiev, Ukraine", 
          "id": "http://www.grid.ac/institutes/grid.419966.5", 
          "name": [
            "Vitamines and Coenzymes Biochemistry Department, Palladin Institute of Biochemistry of NAS, Kiev, Ukraine"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kuchmerovska", 
        "givenName": "Tamara", 
        "id": "sg:person.01150024441.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150024441.16"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/362318a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047914698", 
          "https://doi.org/10.1038/362318a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-005-0023-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005477420", 
          "https://doi.org/10.1007/s00125-005-0023-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/npp.2012.142", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027728579", 
          "https://doi.org/10.1038/npp.2012.142"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10571-010-9532-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000770754", 
          "https://doi.org/10.1007/s10571-010-9532-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11062-010-9118-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045012887", 
          "https://doi.org/10.1007/s11062-010-9118-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11064-007-9283-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025954532", 
          "https://doi.org/10.1007/s11064-007-9283-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrm2336", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024968149", 
          "https://doi.org/10.1038/nrm2336"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002512-200118100-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030769770", 
          "https://doi.org/10.2165/00002512-200118100-00003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00210-011-0636-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007242083", 
          "https://doi.org/10.1007/s00210-011-0636-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/375645a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047364605", 
          "https://doi.org/10.1038/375645a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02462825", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021966742", 
          "https://doi.org/10.1007/bf02462825"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-01-23", 
    "datePublishedReg": "2015-01-23", 
    "description": "Diabetic neuropathy represents one of the most prevalent complications of diabetes mellitus. The aim of this study was to investigate the effect of diabetes-induced disturbances in neurons on the Ca2+-triggered membrane fusion process in cell-free system in relation to plasmalemma cholesterol level. The gabapentin therapy on the exocytosis process was also studied. The diabetes in rats was induced by streptozotocin (60\u00a0mg/kg of body weight, i.p.). After 4\u00a0weeks of diabetes induction the one group of diabetic rats was treated with gabapentin (50\u00a0mg/kg, i.p.) during 1\u00a0month. Fusion experiments were performed in the cell-free model system using fluorescent dye octadecylrhodamine B. The [2-14C]serotonin preloaded synaptosomes were used for assay of stimulated neurotransmitter release. The synaptosomal plasma membrane cholesterol level in diabetic rats was on 12\u00a0% higher than in control and was decreased on 5\u00a0% after gabapentin therapy. The rate of synaptic vesicles fusion with plasma membranes in the presence of Ca2+ and synaptosomal cytosolic proteins was decreased to 14.5\u00a0% in diabetic rats as compared to control (23\u00a0%) and after gabapentin administration to diabetic rats was raised to 18\u00a0%. At diabetes the stimulated synaptosomal serotonin release was increased in 1.7\u20132 folds and was partially normalized by gabapentin therapy. Together, these findings suggest that elevated cholesterol content in neuronal plasma membranes at diabetes impairs the membrane fusion process in neurons that can induce the development of neuropathy. Diabetes-evoked impairments of the exocytotic process can be attenuated by gabapentin therapy.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11064-015-1520-6", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1085962", 
        "issn": [
          "0364-3190", 
          "1573-6903"
        ], 
        "name": "Neurochemical Research", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "40"
      }
    ], 
    "keywords": [
      "gabapentin therapy", 
      "diabetic rats", 
      "cholesterol levels", 
      "diabetes-induced disturbances", 
      "diabetes-induced impairment", 
      "neuronal plasma membrane", 
      "effect of gabapentin", 
      "development of neuropathy", 
      "elevated cholesterol content", 
      "gabapentin administration", 
      "diabetes impairs", 
      "diabetes induction", 
      "diabetic neuropathy", 
      "diabetes mellitus", 
      "prevalent complication", 
      "serotonin release", 
      "rats", 
      "therapy", 
      "neurotransmitter release", 
      "membrane cholesterol levels", 
      "exocytosis process", 
      "neuropathy", 
      "gabapentin", 
      "cholesterol content", 
      "neurons", 
      "impairment", 
      "membrane fusion process", 
      "presence of Ca2", 
      "exocytotic process", 
      "plasma membrane", 
      "synaptic vesicle fusion", 
      "Ca2", 
      "mellitus", 
      "streptozotocin", 
      "complications", 
      "diabetes", 
      "plasma membrane cholesterol levels", 
      "levels", 
      "synaptosomes", 
      "release", 
      "administration", 
      "weeks", 
      "months", 
      "cell-free model system", 
      "cell-free system", 
      "impairs", 
      "cytosolic proteins", 
      "induction", 
      "effect", 
      "B.", 
      "group", 
      "aim", 
      "assays", 
      "findings", 
      "membrane", 
      "control", 
      "study", 
      "model system", 
      "protein", 
      "rate", 
      "disturbances", 
      "presence", 
      "vesicle fusion", 
      "folds", 
      "synaptosomal cytosolic proteins", 
      "development", 
      "fusion", 
      "fusion process", 
      "relation", 
      "system", 
      "link", 
      "process", 
      "content", 
      "experiments", 
      "fusion experiments", 
      "plasmalemma cholesterol level", 
      "fluorescent dye octadecylrhodamine B.", 
      "dye octadecylrhodamine B.", 
      "octadecylrhodamine B.", 
      "synaptosomal plasma membrane cholesterol level", 
      "synaptosomal serotonin release", 
      "Diabetes-evoked impairments"
    ], 
    "name": "Diabetes-Induced Impairments of the Exocytosis Process and the Effect of Gabapentin: The Link with Cholesterol Level in Neuronal Plasma Membranes", 
    "pagination": "723-732", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1022299107"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11064-015-1520-6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25614181"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11064-015-1520-6", 
      "https://app.dimensions.ai/details/publication/pub.1022299107"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:34", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_677.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11064-015-1520-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11064-015-1520-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11064-015-1520-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11064-015-1520-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11064-015-1520-6'


 

This table displays all metadata directly associated to this object as RDF triples.

268 TRIPLES      22 PREDICATES      135 URIs      115 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11064-015-1520-6 schema:about N159f1729fb6b4518b8156d5aaee30c21
2 N5e59da195868470394e16b0673a9cd7d
3 N66295c0273ce4024b4d6988402692298
4 N6e69a9bf47fc45529930735da468a562
5 N708a9c24aab64af4890b4ecb3929d269
6 N9eef764a188147b39d99fbdd663d081a
7 Na99479e3cf224aaab6b664d2bb0abec6
8 Nacbe634e8dae42ef9cb70035636d4251
9 Nb755479e638a430e98f7c2444dabdaf8
10 Nbd4f8b8df9d04945aded6b3ab7e11fe2
11 Nc5dc97d2620a4721b5d6840837e58ba5
12 Nc7673894d2e5463b84f36d36f9a35229
13 Nd9ed42e4287a4c9c82cb61b2c3d26e5f
14 Ne60c1049bcc549068e913e1cade0d51c
15 Nf443b014ee6744bd83c1016b763ddc05
16 anzsrc-for:11
17 anzsrc-for:1103
18 anzsrc-for:1109
19 schema:author Nc8d076a460c646f78106edda746df19e
20 schema:citation sg:pub.10.1007/bf02462825
21 sg:pub.10.1007/s00125-005-0023-4
22 sg:pub.10.1007/s00210-011-0636-8
23 sg:pub.10.1007/s10571-010-9532-x
24 sg:pub.10.1007/s11062-010-9118-8
25 sg:pub.10.1007/s11064-007-9283-3
26 sg:pub.10.1038/362318a0
27 sg:pub.10.1038/375645a0
28 sg:pub.10.1038/npp.2012.142
29 sg:pub.10.1038/nrm2336
30 sg:pub.10.2165/00002512-200118100-00003
31 schema:datePublished 2015-01-23
32 schema:datePublishedReg 2015-01-23
33 schema:description Diabetic neuropathy represents one of the most prevalent complications of diabetes mellitus. The aim of this study was to investigate the effect of diabetes-induced disturbances in neurons on the Ca2+-triggered membrane fusion process in cell-free system in relation to plasmalemma cholesterol level. The gabapentin therapy on the exocytosis process was also studied. The diabetes in rats was induced by streptozotocin (60 mg/kg of body weight, i.p.). After 4 weeks of diabetes induction the one group of diabetic rats was treated with gabapentin (50 mg/kg, i.p.) during 1 month. Fusion experiments were performed in the cell-free model system using fluorescent dye octadecylrhodamine B. The [2-14C]serotonin preloaded synaptosomes were used for assay of stimulated neurotransmitter release. The synaptosomal plasma membrane cholesterol level in diabetic rats was on 12 % higher than in control and was decreased on 5 % after gabapentin therapy. The rate of synaptic vesicles fusion with plasma membranes in the presence of Ca2+ and synaptosomal cytosolic proteins was decreased to 14.5 % in diabetic rats as compared to control (23 %) and after gabapentin administration to diabetic rats was raised to 18 %. At diabetes the stimulated synaptosomal serotonin release was increased in 1.7–2 folds and was partially normalized by gabapentin therapy. Together, these findings suggest that elevated cholesterol content in neuronal plasma membranes at diabetes impairs the membrane fusion process in neurons that can induce the development of neuropathy. Diabetes-evoked impairments of the exocytotic process can be attenuated by gabapentin therapy.
34 schema:genre article
35 schema:inLanguage en
36 schema:isAccessibleForFree false
37 schema:isPartOf Na18bd13509564db6b08ecbcab37e7ee5
38 Na7b9fee7ddf9459ea0c6085cc239f211
39 sg:journal.1085962
40 schema:keywords B.
41 Ca2
42 Diabetes-evoked impairments
43 administration
44 aim
45 assays
46 cell-free model system
47 cell-free system
48 cholesterol content
49 cholesterol levels
50 complications
51 content
52 control
53 cytosolic proteins
54 development
55 development of neuropathy
56 diabetes
57 diabetes impairs
58 diabetes induction
59 diabetes mellitus
60 diabetes-induced disturbances
61 diabetes-induced impairment
62 diabetic neuropathy
63 diabetic rats
64 disturbances
65 dye octadecylrhodamine B.
66 effect
67 effect of gabapentin
68 elevated cholesterol content
69 exocytosis process
70 exocytotic process
71 experiments
72 findings
73 fluorescent dye octadecylrhodamine B.
74 folds
75 fusion
76 fusion experiments
77 fusion process
78 gabapentin
79 gabapentin administration
80 gabapentin therapy
81 group
82 impairment
83 impairs
84 induction
85 levels
86 link
87 mellitus
88 membrane
89 membrane cholesterol levels
90 membrane fusion process
91 model system
92 months
93 neuronal plasma membrane
94 neurons
95 neuropathy
96 neurotransmitter release
97 octadecylrhodamine B.
98 plasma membrane
99 plasma membrane cholesterol levels
100 plasmalemma cholesterol level
101 presence
102 presence of Ca2
103 prevalent complication
104 process
105 protein
106 rate
107 rats
108 relation
109 release
110 serotonin release
111 streptozotocin
112 study
113 synaptic vesicle fusion
114 synaptosomal cytosolic proteins
115 synaptosomal plasma membrane cholesterol level
116 synaptosomal serotonin release
117 synaptosomes
118 system
119 therapy
120 vesicle fusion
121 weeks
122 schema:name Diabetes-Induced Impairments of the Exocytosis Process and the Effect of Gabapentin: The Link with Cholesterol Level in Neuronal Plasma Membranes
123 schema:pagination 723-732
124 schema:productId N3ce49332163948a094e0f416aeefe82c
125 N977b16ee893747bbbc493c42918f7eb2
126 Nb282caa683ef4244b5172f66d15882d8
127 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022299107
128 https://doi.org/10.1007/s11064-015-1520-6
129 schema:sdDatePublished 2021-12-01T19:34
130 schema:sdLicense https://scigraph.springernature.com/explorer/license/
131 schema:sdPublisher N608bed8ed4a14b5d84fd7aaa7a843f67
132 schema:url https://doi.org/10.1007/s11064-015-1520-6
133 sgo:license sg:explorer/license/
134 sgo:sdDataset articles
135 rdf:type schema:ScholarlyArticle
136 N159f1729fb6b4518b8156d5aaee30c21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Male
138 rdf:type schema:DefinedTerm
139 N3ce49332163948a094e0f416aeefe82c schema:name dimensions_id
140 schema:value pub.1022299107
141 rdf:type schema:PropertyValue
142 N5e59da195868470394e16b0673a9cd7d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Gabapentin
144 rdf:type schema:DefinedTerm
145 N608bed8ed4a14b5d84fd7aaa7a843f67 schema:name Springer Nature - SN SciGraph project
146 rdf:type schema:Organization
147 N66295c0273ce4024b4d6988402692298 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Cyclohexanecarboxylic Acids
149 rdf:type schema:DefinedTerm
150 N6e69a9bf47fc45529930735da468a562 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Cholesterol
152 rdf:type schema:DefinedTerm
153 N708a9c24aab64af4890b4ecb3929d269 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Cell Membrane
155 rdf:type schema:DefinedTerm
156 N8f8cf6b1ea5a420ea41d92c609bd6ad4 rdf:first sg:person.01137345775.17
157 rdf:rest Nf79b2a39c79e4b45b0b8ee425814f963
158 N977b16ee893747bbbc493c42918f7eb2 schema:name doi
159 schema:value 10.1007/s11064-015-1520-6
160 rdf:type schema:PropertyValue
161 N9eef764a188147b39d99fbdd663d081a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Amines
163 rdf:type schema:DefinedTerm
164 Na18bd13509564db6b08ecbcab37e7ee5 schema:issueNumber 4
165 rdf:type schema:PublicationIssue
166 Na7b9fee7ddf9459ea0c6085cc239f211 schema:volumeNumber 40
167 rdf:type schema:PublicationVolume
168 Na99479e3cf224aaab6b664d2bb0abec6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name gamma-Aminobutyric Acid
170 rdf:type schema:DefinedTerm
171 Nacbe634e8dae42ef9cb70035636d4251 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Rats, Wistar
173 rdf:type schema:DefinedTerm
174 Nb282caa683ef4244b5172f66d15882d8 schema:name pubmed_id
175 schema:value 25614181
176 rdf:type schema:PropertyValue
177 Nb755479e638a430e98f7c2444dabdaf8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Diabetic Neuropathies
179 rdf:type schema:DefinedTerm
180 Nbd4f8b8df9d04945aded6b3ab7e11fe2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Exocytosis
182 rdf:type schema:DefinedTerm
183 Nc5dc97d2620a4721b5d6840837e58ba5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Neurons
185 rdf:type schema:DefinedTerm
186 Nc7673894d2e5463b84f36d36f9a35229 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Brain
188 rdf:type schema:DefinedTerm
189 Nc8d076a460c646f78106edda746df19e rdf:first sg:person.060040255.77
190 rdf:rest N8f8cf6b1ea5a420ea41d92c609bd6ad4
191 Nd9ed42e4287a4c9c82cb61b2c3d26e5f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Serotonin
193 rdf:type schema:DefinedTerm
194 Ne60c1049bcc549068e913e1cade0d51c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Rats
196 rdf:type schema:DefinedTerm
197 Nf443b014ee6744bd83c1016b763ddc05 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Animals
199 rdf:type schema:DefinedTerm
200 Nf79b2a39c79e4b45b0b8ee425814f963 rdf:first sg:person.01150024441.16
201 rdf:rest rdf:nil
202 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
203 schema:name Medical and Health Sciences
204 rdf:type schema:DefinedTerm
205 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
206 schema:name Clinical Sciences
207 rdf:type schema:DefinedTerm
208 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
209 schema:name Neurosciences
210 rdf:type schema:DefinedTerm
211 sg:journal.1085962 schema:issn 0364-3190
212 1573-6903
213 schema:name Neurochemical Research
214 schema:publisher Springer Nature
215 rdf:type schema:Periodical
216 sg:person.01137345775.17 schema:affiliation grid-institutes:grid.419966.5
217 schema:familyName Gumenyuk
218 schema:givenName Vitaliy
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137345775.17
220 rdf:type schema:Person
221 sg:person.01150024441.16 schema:affiliation grid-institutes:grid.419966.5
222 schema:familyName Kuchmerovska
223 schema:givenName Tamara
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150024441.16
225 rdf:type schema:Person
226 sg:person.060040255.77 schema:affiliation grid-institutes:grid.419966.5
227 schema:familyName Trikash
228 schema:givenName Irene
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.060040255.77
230 rdf:type schema:Person
231 sg:pub.10.1007/bf02462825 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021966742
232 https://doi.org/10.1007/bf02462825
233 rdf:type schema:CreativeWork
234 sg:pub.10.1007/s00125-005-0023-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005477420
235 https://doi.org/10.1007/s00125-005-0023-4
236 rdf:type schema:CreativeWork
237 sg:pub.10.1007/s00210-011-0636-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007242083
238 https://doi.org/10.1007/s00210-011-0636-8
239 rdf:type schema:CreativeWork
240 sg:pub.10.1007/s10571-010-9532-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1000770754
241 https://doi.org/10.1007/s10571-010-9532-x
242 rdf:type schema:CreativeWork
243 sg:pub.10.1007/s11062-010-9118-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045012887
244 https://doi.org/10.1007/s11062-010-9118-8
245 rdf:type schema:CreativeWork
246 sg:pub.10.1007/s11064-007-9283-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025954532
247 https://doi.org/10.1007/s11064-007-9283-3
248 rdf:type schema:CreativeWork
249 sg:pub.10.1038/362318a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047914698
250 https://doi.org/10.1038/362318a0
251 rdf:type schema:CreativeWork
252 sg:pub.10.1038/375645a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047364605
253 https://doi.org/10.1038/375645a0
254 rdf:type schema:CreativeWork
255 sg:pub.10.1038/npp.2012.142 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027728579
256 https://doi.org/10.1038/npp.2012.142
257 rdf:type schema:CreativeWork
258 sg:pub.10.1038/nrm2336 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024968149
259 https://doi.org/10.1038/nrm2336
260 rdf:type schema:CreativeWork
261 sg:pub.10.2165/00002512-200118100-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030769770
262 https://doi.org/10.2165/00002512-200118100-00003
263 rdf:type schema:CreativeWork
264 grid-institutes:grid.419966.5 schema:alternateName Neurochemistry Department, Palladin Institute of Biochemistry of NAS, Kiev, Ukraine
265 Vitamines and Coenzymes Biochemistry Department, Palladin Institute of Biochemistry of NAS, Kiev, Ukraine
266 schema:name Neurochemistry Department, Palladin Institute of Biochemistry of NAS, Kiev, Ukraine
267 Vitamines and Coenzymes Biochemistry Department, Palladin Institute of Biochemistry of NAS, Kiev, Ukraine
268 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...